Cargando…
Combining ketamine with astrocytic inhibitor as a potential analgesic strategy for neuropathic pain. ketamine, astrocytic inhibitor and pain
BACKGROUND: Neuropathic pain is an intractable clinical problem. Intrathecal ketamine, a noncompetitive N--methyl-D-aspartate receptor (NMDAR) antagonist, is reported to be useful for treating neuropathic pain in clinic by inhibiting the activity of spinal neurons. Nevertheless, emerging studies hav...
Autores principales: | Mei, Xiao-Peng, Wang, Wei, Wang, Wen, Zhu, Chao, Chen, Lei, Zhang, Ting, Xu, Li-Xian, Wu, Sheng-Xi, Li, Yun-Qing |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2942826/ https://www.ncbi.nlm.nih.gov/pubmed/20815929 http://dx.doi.org/10.1186/1744-8069-6-50 |
Ejemplares similares
-
Inhibition of spinal astrocytic c-Jun N-terminal kinase (JNK) activation correlates with the analgesic effects of ketamine in neuropathic pain
por: Mei, Xiao-Peng, et al.
Publicado: (2011) -
The analgesic effects of β-elemene in rats with neuropathic pain by
inhibition of spinal astrocytic ERK activation
por: Ma, Li-Tian, et al.
Publicado: (2022) -
The role of astrocytes in neuropathic pain
por: Cheng, Tong, et al.
Publicado: (2022) -
The Inhibition of Spinal Astrocytic JAK2-STAT3 Pathway Activation Correlates with the Analgesic Effects of Triptolide in the Rat Neuropathic Pain Model
por: Tang, Jun, et al.
Publicado: (2012) -
Inhibition of astrocyte activation is involved in the prevention of postoperative latent pain sensitization by ketamine and gabapentin in mice
por: Romero-Alejo, Elizabeth, et al.
Publicado: (2016)